Author

Pinelopi Michalopoulou

Observed names: Michalopoulou Pinelopi, P Michalopoulou, P. Michalopoulou, Pinelopi MICHALOPOULOU

Observed institutions: Henry Dunant Hospital, Sotiria General Hospital

OpenAlex ID: A5079974723

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial

2010 · G.P. Stathopoulos, D. Antoniou, et al. · Annals of Oncology · 124

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer

2011 · G. P. Stathopoulos, D. Antoniou, et al. · Cancer Chemotherapy and Pharmacology · 104

Front-line paclitaxel–vinorelbine versus paclitaxel–carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial

2004 · G.P. Stathopoulos, M. Veslemes, et al. · Annals of Oncology · 60

Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease

2009 · Angeliki M. TSIMOGIANNI, Spyros A. PAPIRIS, et al. · Respirology · 28

Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial

2005 · G P Stathopoulos, J Dimitroulis, et al. · British Journal of Cancer · 26

Study of Inflammatory Biomarkers in COPD and Asthma Exacerbations

2020 · Alice Vassiliou, Vlassios Vitsas, et al. · Advances in respiratory medicine · 19

Mesothelioma: treatment and survival of a patient population and review of the literature.

2005 · John Stathopoulos, Dimosthenis Antoniou, et al. · PubMed · 10

Biomarkers in COPD- The role of resistin and leptin

2015 · Vlasios Vitsas, Kardara Matina, et al. · European Respiratory Journal · 4

Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study.

2006 · J Dimitroulis, M Toubis, et al. · PubMed · 4

Comparison of response rate of advanced non-small lung cancer patients to liposomal cisplatin versus cisplatin both combined with paclitaxel: A phase III trial.

2010 · G. Stathopoulos, D. Antoniou, et al. · Journal of Clinical Oncology · 2

Biomarkers in COPD exacerbation, the role of adiponectin

2014 · Vlasios Vitsas, Matina Kardara, et al. · European Respiratory Journal · 1

Liposomal cisplatin and paclitaxel versus cisplatin and paclitaxel in advanced NSCLC

2007 · G. P. Stathopoulos, P. Michalopoulou, et al. · Journal of Clinical Oncology · 1

Alternative administration of paclitaxel-gemcitabine and paclitaxel-vinorelbine as first line treatment in NSCLC patients. A phase II study

2005 · J. Dimitroulis, M. Toubis, et al. · Journal of Clinical Oncology

Front line chemotherapy in advanced NSCLC with paclitaxel and irinotecan combination

2004 · G. P. Stathopoulos, D. Antoniou, et al. · Journal of Clinical Oncology

229 The management of small cell lung cancer (SCLC) with alternating chemotherapeutic regimens CAV-PE

1997 · G. Bla-zogiannakis, Hr. Ageletopoulou, et al. · Lung Cancer

Works count: 16

Citation count: 383

H-index: 7

I10-index: 7